Peripheral Blood Stem Cell TransplantationHematopoietic Stem Cell TransplantationTransplantation, HomologousBone Marrow TransplantationGraft vs Host DiseaseTransplantation, AutologousTransplantation ConditioningHematologic NeoplasmsHematopoietic Stem Cell MobilizationGranulocyte Colony-Stimulating FactorTransplantation ChimeraGraft SurvivalTissue DonorsBusulfanAntigens, CD34Stem CellsImmunosuppressive AgentsTreatment OutcomeLeukapheresisBone MarrowVidarabineHematopoietic Stem CellsRecurrenceBone Marrow CellsStem Cell TransplantationWhole-Body IrradiationHistocompatibilityLeukemiaHistocompatibility TestingGraft vs Leukemia EffectRetrospective StudiesBlood Component RemovalCyclophosphamideSurvival AnalysisCombined Modality TherapyMelphalanMyeloablative AgonistsAnemia, AplasticChronic DiseaseMultiple MyelomaBone Marrow PurgingAntineoplastic Combined Chemotherapy ProtocolsHematopoiesisLymphoma, Non-HodgkinPrecursor Cell Lymphoblastic Leukemia-LymphomaCord Blood Stem Cell TransplantationRemission InductionT-LymphocytesDisease-Free SurvivalTransplantation, IsogeneicHLA AntigensTime FactorsBlood CellsCytomegalovirus InfectionsBone and BonesLeukemia, Myeloid, AcuteTransplantation ImmunologyLeukemia, Myelogenous, Chronic, BCR-ABL PositiveEmbryonic Stem CellsBone Marrow DiseasesEtoposideBlood Cell CountCyclosporineCell DifferentiationAdult Stem CellsLymphocyte DepletionLeukocyte TransfusionHematologic DiseasesKidney TransplantationSurvival RateFlow CytometryAcute DiseaseImmunosuppressionInfectionOpportunistic InfectionsColony-Forming Units AssayLiver TransplantationMice, Inbred C57BLSalvage TherapyLymphocyte TransfusionMyelodysplastic SyndromesCytarabineTransplantationCells, CulturedThiotepaCell SeparationAntineoplastic Agents, AlkylatingHodgkin DiseaseImmunocompromised HostLeukemia, MyeloidGraft RejectionPluripotent Stem CellsLymphomaHepatic Veno-Occlusive DiseaseFollow-Up StudiesLeukocyte CountImmunophenotypingBlood DonorsRecombinant ProteinsMesenchymal Stem Cell Transplantation